Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G,
Providers can sign up for early access here: To view or add a comment, sign in More Relevant Posts PCAC Meeting Day 1 Results: BPC-157: YES KPV: YES TB-500: YES MOTS-c: YES Today the FDA's Pharmacy Compounding Advisory Committee voted to recommend all four peptides reviewed today for inclusion on the 503A Bulks List
Both act through the ghrelin/GHSR pathway, but Ipamorelin is generally discussed as more selective, while GHRP-6 is an older GH-releasing peptide often associated with appetite-related signaling
Studies suggest that sermorelin, in combination with arginine, may serve as a specific test for growth hormone deficiency, particularly in children
These foundational approaches support natural GH function and should precede consideration of any pharmacological intervention